Also, CCH disrupts the sphingolipid metabolism by affecting the mRNA expression of SMPD1 and SMS2, leading to the accumulation of sphingomyelin in the prefrontal cortex. The gene discussed is SMPD1; the disease is columnar cell hyperplasia of the breast.